GLP1R and chronic obstructive pulmonary disease: Chronic respiratory conditions, particularly asthma and chronic obstructive pulmonary disease, represent significant emerging applications supported by GLP-1 receptor expression throughout the bronchial epithelium, airway smooth muscle, and pulmonary immune cells (Table 11) [145,146].